Devonian Health Group Inc DVHGF

Primary Symbol: V.GSD

Healthcare

Devonian Health Group Inc. is a Canada-based late-stage botanical pharmaceutical company. The Company's main activity is the development of botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases, including ulcerative colitis and atopic dermatitis. It is also involved in the development of value-added products for dermo-cosmetics and the distribution of pharmaceutical products through its subsidiary. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The Company's cosmeceutical products include R-Spinasome and Purgenesis.

TSXV:GSD - Post by User

Devonian Health Group Inc > Chefboy69

<< Previous

Bullboard Posts

Next >>

Comment by wallywagonon Dec 11, 2021 3:59pm

167 Views

Post# 34222070

RE:RE:Chefboy69

Ok Fine then. Good luck to you too. A slow drag race here. Things should be moving much quicker
if not for CEO. Wasted all year to get anything done and didnt do much at all and did not capitalize on Phase 2 glowing results. At 42 cents you are good. We need to get over that $100 Million evaluation or a US Stcok listing to generate more buying.

<< Previous

Bullboard Posts

Next >>

Critical raw materials pioneer drives Europe’s clean energy transition